ArticleOncology reports2024

Expression of EGFRvIII and its co‑expression with wild‑type EGFR, or putative cancer stem cell biomarkers CD44 or EpCAM are associated with poorer prognosis in patients with hepatocellular carcinoma.

Ozlem Sherif et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.